期刊文献+

唑来膦酸对兔胫骨骨折愈合的影响 被引量:1

Effects of zoledronic acid on healing of tibial fracture in rabbits
下载PDF
导出
摘要 目的观察注射用唑来膦酸对兔胫骨骨折愈合的影响。方法 30只新西兰大白兔制成胫骨中段骨折、钢板螺钉内固定骨折模型,随后随机分为实验组和对照组。实验组在术后注射唑来膦酸0.1 mg/kg,对照组注射同样剂量的生理盐水。在骨折模型建立后的第1、2、3、4、6周,通过X线观察骨折愈合情况,并测定血清碱性磷酸酶(alkaline phosphatase,ALP)及血清抗酒石酸酸性磷酸酶5b(tartrate resistant acid phosphatase-5b,TRAP-5b)水平。在建模后的第2、3、4、6周,测定骨折端骨密度。结果实验组血清ALP水平均高于对照组;第3、4周,实验组外骨痂平均面积较对照组大,但差异均无统计学意义(P>0.05)。同阶段对比,实验组TRAP-5b水平均较对照组低,差异有统计学意义(P<0.05)。实验组骨密度多数观察时间高于对照组,第4周时两组差异具有统计学意义(P<0.05)。结论注射用唑来膦酸对稳定固定的兔胫骨横断骨折的愈合可能具有一定的促进作用。 Objective To evaluate the effects of zoledronic acid on the healingof tibial fracture in rabbits. Methods Tibial fractures were induced in 30 NewZealand white rabbits and immobilized with a plate and six screws. The animals were randomly divided intotreatment group and control group: in treatment group zoledronic acid was administered by intravenous injection(0. 1 mg/ kg) a fter fracture,while animals in control group were injected with same volume of normal saline. The states of fracture healingwere examined and then scored by X-ray at week 1,2,3,4 and 6 after fracture. The levels of serum ALP and tartrate-resistant acid phosphatase 5b( TRAP-5b) were assayed,and the bone mineral density at fracture-healingsite was detected at the same time points. Results There were nosignificance differences in serum ALP levels and the area of external callus between treatment and control groups,although there was a trend of increase at week 3 and 4 after fracture. The mean TRAP-5b level of treatment group was lower than that of control group at all time points( P〈0. 05). The average bone mineral density at fracture-healingsite in treatment group was greater than that in controlgroup at week 4( P〈0. 05). Conclusion Systemic administration of zoledronic acid may be effective for healing of tibial fracture under stable fixation in rabbits.
出处 《同济大学学报(医学版)》 CAS 2014年第5期42-46,共5页 Journal of Tongji University(Medical Science)
关键词 唑来膦酸 胫骨骨折 Zoledronic acid tibial fracture rabbit
  • 相关文献

参考文献7

  • 1Borrelli J Jr,Prickett WD,Ricci WM.Treatment of nonunions and osseous defects with bone graft and calcium sulfate[J].Clin Orthop Relat Res,2003(411):245-254.
  • 2Rodan GA,Martin TJ.Role of osteoblasts in hormonal control of bone resorption-a hypothesis[J].Calcif Tissue Int,1981,33(4); 349-351.
  • 3Rogers MJ,Gordon S,Benford HL,et al.Cellular and molecular mechanisms of action of bisphosph- onates[J].Cancer,2000,88(12 Suppl):2961- 2978.
  • 4Frith JC,Monkkonen J,Auriola S,et al.The molecular mechanism of action of the anti-resorptive and anti-inflammatory drug clodronate:evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis[J].Arthritis Rheum,2001,44(9):2201- 2210.
  • 5Amanat N,He LH,Swain MV,et al.The effect of zoledronic acid on the intrinsic material properties of healing bone:an indentation study[J].Med Eng Phys,2008,30(7):843-847.
  • 6Yu X,Collin-Osdoby P,Osdoby P.SDF-I increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity[J].Connect Tissue Res,2003,44(Suppl I):79- 84.
  • 7Hayman AR,Cox TM.Purpose acid phosphatase of the human macrophage and osteoclast,characterization,molecular prosperties,and crystallization of the recom- binant di-iron-oxo protein secreted by baculovirusin- fected insect cells[J].J Biol Chem,1994,269(2);1294-1300.

同被引文献16

  • 1刘学军.骨质疏松症[J].中国矫形外科杂志,2006,14(21):1668-1670. 被引量:26
  • 2Cao L,Liu G,Gan Y,et al. The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long- term estrogen deficient goats. Biomaterials, 2012,33 ( 20 ) : 5076- 5084.
  • 3Brun LR,Galich AM, Vega E, et al. Strontium ranelate effect on bone mineral density is modified by previous bisphosphouate treatment. Springer Plus ,2014,3 ( 1 ) :676.
  • 4Chen B, Li Y, Yang X, et al. Zoledronic acid enhances bone- implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats. Osteoporosis International,2013, 24(7) :2115-2t21.
  • 5Cao Y, Mori S, Mashiba T, et al. Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats. Journal of Bone and Mineral Research,2002, 17 ( 12 ) :2237-2246.
  • 6Rudert M. Histological evaluation of osteochondral defects: consideration of animal models with emphasis on the rabbit, experimental setup, follow-up and applied methods. Cells Tissues Organs,2002,171 ( 4 ) : 229-240.
  • 7Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clinic Proceedings, 2008,83 (9) : 1032-1045.
  • 8Kwak HB, Kim JY, Kim KJ, et al. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biological and Pharmaceutical Bulletin, 2009,32 ( 7 ) : 1193-1198.
  • 9Rogers MJ, Gordon S, Benford H, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer, 2000, 88 (S12) :2961-2978.
  • 10Takahashi N, Sasaki T, Tsouderos Y, et al. S 12911-2 inhibits osteoclastic bone resorption in vitro. Journal of Bone and Mineral Research ,2003,18 ( 6 ) : 1082-1087.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部